In:
EJNMMI Radiopharmacy and Chemistry, Springer Science and Business Media LLC, Vol. 8, No. 1 ( 2023-03-23)
Abstract:
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body This selection of highlights provides commentary on 21
different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human
application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are
highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field, and include new
PET-labelling methods for 11 C and 18 F, the importance of
choosing the proper chelator for a given radioactive metal ion, implications of total body PET on use of radiopharmaceuticals, legislation issues and
radionuclide therapy including the emerging role of 161 Tb.
Type of Medium:
Online Resource
ISSN:
2365-421X
DOI:
10.1186/s41181-023-00192-5
Language:
English
Publisher:
Springer Science and Business Media LLC
Publication Date:
2023
detail.hit.zdb_id:
2843088-8
Bookmarklink